|
03.03.2021 15:53:00
|
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2021
STOCKHOLM, March 3, 2021 /PRNewswire/ -- Strong sales growth during February; Zinzino group revenue increased with a total of 33%, compared with the previous year.
The revenue in February for Zinzino's sales markets increased by 30% to SEK 94.4 (72.5) million due to strong growth in several regions.
Faun Pharma's external sales increased by 81% and amounted to SEK 6.7 (3.7) million. Overall, the Group increased revenues by 33% to SEK 101.1 (76.2) million compared with the previous year.
Accumulated revenue for January - February 2021 increased by 29% SEK 208.1 (161.9) million.
Revenues were distributed as follows:
Regions,MSEK |
21-feb |
20-feb |
Change |
YTD 2021 |
YTD 2020 |
Change
|
The Nordics |
27.5 |
29.5 |
-7% |
57.5 |
62.3 |
-8%
|
Central Europe |
16.7 |
10.4 |
61% |
34.9 |
23.1 |
51%
|
East Europe |
22.3 |
19.4 |
15% |
49.6 |
39.2 |
27%
|
South & West Europe |
11.5 |
4.2 |
174% |
21.5 |
8.0 |
169%
|
The Baltics |
5.5 |
5.2 |
6% |
11.3 |
10.8 |
5%
|
North America |
3.8 |
2.7 |
41% |
7.4 |
5.3 |
40%
|
Asia-Pacific |
7.1 |
1.1 |
545% |
13.8 |
2.6 |
431%
|
Zinzino |
94.4 |
72.5 |
30% |
196.0 |
151.3 |
30%
|
Faun Pharma |
6.7 |
3.7 |
81% |
12.1 |
10.6 |
14%
|
Zinzino Group |
101.1 |
76.2 |
33% |
208.1 |
161.9 |
29%
|
Countries in regions:
- The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
- Central Europe: Austria, Germany, Switzerland
- East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
- South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom
- The Baltics: Estonia, Latvia, Lithuania
- North America: Canada, USA
- Asia-Pacific: Australia, Hong Kong, Malaysia, Singapore, Taiwan, Thailand
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ.) är ett globalt företag inom direktförsäljning som marknadsför och säljer testbaserade kosttillskotts-, hudvårds- och livsstilsprodukter. Zinzino äger forskningsenheten BioActive Foods AS och produktionsenheten Faun Pharma AS. Zinzinos huvudkontor ligger i Göteborg, och företaget har även kontor i Finland, Lettland, Norge, USA, Australien, Hongkong och Malaysia. Zinzino är ett aktiebolag noterat på Nasdaq First North Premier Growth Market.
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:30 the 3rd of March 2021.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-february-2021,c3299682
The following files are available for download:
https://mb.cision.com/Main/10976/3299682/1381959.pdf | Pressrelease Sale Report February |
https://news.cision.com/zinzino/i/dag-berhem-pettersen-5a6a9512,c2884456 | Dag-Berhem-Pettersen-5A6A9512 |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Zinzino Holding AB (B)mehr Nachrichten
|
18.11.24 |
Ausblick: Zinzino B stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
|
04.11.24 |
Erste Schätzungen: Zinzino B verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
|
29.08.24 |
Ausblick: Zinzino B zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
|
15.08.24 |
Erste Schätzungen: Zinzino B präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Zinzino Holding AB (B)mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.